Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02005445 · ClinicalTrials.gov registry record · NA
Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02005445: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT02005445 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02005445, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a randomized clinical trial in U.S. Veterans to evaluate the impact of treatment for obstructive sleep apnea (OSA) on the effectiveness of cardiac rehabilitation, including impact on exercise capacity, disability, and quality of life.
Primary Outcome
Functional status as measured by the World Health Organization Disability Assessment Scale 2.0. Score range 0-48 (higher scores indicate more disability).
Interventions
- DEVICE CPAP
- BEHAVIORAL HLSE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2018-06-29 |
| Phase | NA |
Why NCT02005445 stopped before completion
NCT02005445 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which CPAP is the first listed.
NCT02005445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02005445 about?
NCT02005445 is a clinical study titled "Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation". This is a randomized clinical trial in U.S. Veterans to evaluate the impact of treatment for obstructive sleep apnea (OSA) on the effectiveness of cardiac rehabilitation, including impact on exercise capacity, disability, and quality of life.
What is the current status of trial NCT02005445?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-10-01. Estimated completion is 2018-06-29.
What interventions are being tested in trial NCT02005445?
The interventions under investigation include: CPAP (DEVICE), HLSE (BEHAVIORAL).
Who is sponsoring clinical trial NCT02005445?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02005445's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI